Publication | Open Access
ADAMTS 1, 4, 12, and 13 levels in maternal blood, cord blood, and placenta in preeclampsia
23
Citations
27
References
2017
Year
FertilityFetal MedicineGynecologyPathologyPreeclampsia GroupMaternal BloodWhereas Adamts 13EmbryologyHigh-risk PregnancyHematologyReproductive MedicineAdamts 1Public HealthPreeclampsiaPlacental DevelopmentInfertilityMaternal Cardiovascular OutcomeMaternal HealthPlacental DiseaseCord BloodMaternal-fetal MedicineEndocrinologyPlacental FunctionDevelopmental BiologyPregnancyMedicine
The aim of this study is to compare ADAMTS (A Disintegrin and Metalloprotease Domains with Thrombospondins motifs) 1, 4, 12, and 13 levels in maternal and cord blood and placental tissue between preeclampsia and uncomplicated pregnancies. The enzyme-linked immunosorbent assay (ELISA) results showed that ADAMTS 1, 4, 12, and 13 levels in the maternal and cord blood were lower in the preeclampsia group than in the control group. Based on the immunohistochemistry (IHC) results, ADAMTS 1, 4, and 12 levels in placental tissues were higher in the preeclampsia group. According to the polymerase chain reaction (PCR) results, ADAMTS 1, 4, and 12 were higher, whereas ADAMTS 13 was lower in the preeclampsia group than in the control group.
| Year | Citations | |
|---|---|---|
Page 1
Page 1